A more recent retrospective cohort study by Michaelson-Cohen investigated the risk of breast cancer after RRSO in 306 non-diseased BRCA1/2-pV carriers (Michaelson-Cohen et al. 2021). The gene discussed is BRCA1; the disease is breast cancer.